Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:24 Mar 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1286.75 [ +1.06% ]TCS 2427.20 [ -1.35% ]

Sensex29421.40
89.24 0.30%

Nifty9108.00
21.70 0.24%

Midcap13849.18
-4.22 -0.03%

Smallcap14077.61
49.67 0.35%



Glenmark Pharmaceuticals Ltd :

 886.55   -8.95(1%)

ISIN: INE935A01035  | BSE : GLENMARK  |  Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln  | Add To Watchlist

Price Information
• Open 896.50
• High 898.15
• Low 883.10
• Previous Close 895.50
• Shares Traded 49431400
• 52 Wk High Price 994.00
• 52 Wk High Date 01-11-2016
• 52 Wk Low Price 730.00
• 52 Wk Low Date 24-06-2016
• Face Value 1.00


Fundamentals
• Market Capital (Rs.cr) 25197.10
• EPS (Rs.)(TTM) 80.83
• P/E Ratio(TTM) 11.05
• Book Value (Rs.) 258.20
• Price to Book Value 3.46
• Equity (Rs.cr.) 28.22
• Traded Value (Rs.lac) 336.36


Corporate Actions
Ex-Date Purpose (Rs.)
2011-07-28 40% Dividend (0.4)
2012-07-19 200% Dividend (2)
2013-07-18 200% Dividend (2)
2014-07-10 200% Dividend (2)
2016-08-03 200% Dividend (2)


Index Names
BSE-500
BSE HC
BSE-100
CNX Nifty Jr.
BSE-200




Key Financials Latest Qrtr. Trailing Yr. Full Yr.
• Year End Dec, 2016 Dec, 2016 Mar, 2016
• Sales (Rs.cr) 2114.95 7842.04 6273.24
• Net Profit (Rs.cr) 711.31 2281.07 1469.05
• Net Profit Var (%) 170.00 28.00 29.00
• EPS (Rs) - 80.83 51.60
• P/E Ratio - 11.05 17.30
• Operating Profit Margin - 34.85 -
• CPS (Rs.) - - 55.60
• P/C Ratio - - 16.10
• Div% - - 200.00

Announcements
01-06-2016 Glenmark Pharmaceuticals Limited - FCCBs
09-05-2016 Glenmark Pharmaceuticals Limited - Updates
06-05-2015 Glenmark Pharmaceuticals Limited - Addendum
13-01-2016 Glenmark Pharmaceuticals Limited - Updates
21-02-2017 Glenmark Pharmaceuticals Limited - Updates
05-06-2015 Glenmark Pharmaceuticals Limited - Extraordinary General Meeting Updates
23-08-2012 Glenmark Pharmaceuticals - Press Release
24-10-2016 Glenmark Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Update
11-01-2017 Glenmark Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
12-02-2016 Glenmark Pharmaceuticals Limited - Extraordinary General Meeting Updates
24-12-2015 Glenmark Pharmaceuticals Limited - Postal Ballot Updates
10-04-2015 Glenmark Pharmaceuticals Limited - Press Release
03-02-2017 Glenmark Pharmaceuticals Limited - Appointment of Company Secretary/Compliance Officer
21-04-2016 Glenmark Pharmaceuticals Limited - Clarification
23-10-2015 Glenmark Pharmaceuticals Limited - Press Release
30-10-2016 Glenmark Pharmaceuticals Limited - Resignation of CompanySecretary/Compliance Officer
05-11-2014 Glenmark Pharmaceuticals Limited - 4 Press Release
29-05-2015 Glenmark Pharmaceuticals Limited - Press Release
12-10-2015 Glenmark Pharmaceuticals Limited - Annual General Meeting Updates
13-10-2014 Glenmark Pharmaceuticals Limited - ESOPs/ESOS/ESPS
05-01-2016 Glenmark Pharmaceuticals Limited - News Clarification
21-12-2015 Glenmark Pharmaceuticals Limited - Press Release
27-11-2014 Glenmark Pharmaceuticals Limited - Resignation of Director
16-12-2015 Glenmark Pharmaceuticals Limited - ESOPs/ESOS/ESPS
20-04-2015 Glenmark Pharmaceuticals Limited - Outcome of Board Meeting
02-03-2017 Glenmark Pharmaceuticals Limited - Press Release
16-10-2015 Glenmark Pharmaceuticals Limited - Trading Window
20-05-2015 Glenmark Pharmaceuticals Limited - Allotment of Securities
19-09-2014 Glenmark Pharmaceuticals Limited - Disclosure under Insider Trading Regulation
30-10-2015 Glenmark Pharmaceuticals Limited - Outcome of Board Meeting
01-06-2015 Glenmark Pharmaceuticals Limited - Resignation of Director
17-12-2014 Glenmark Pharmaceuticals Limited - Court Convened Meeting Updates
23-03-2015 Glenmark Pharmaceuticals Limited - News Clarification
26-02-2015 Glenmark Pharmaceuticals Limited - Press Release
15-07-2014 Glenmark Pharmaceuticals Limited - Press Release
04-07-2012 Glenmark Pharmaceuticals Limited - AGM / Book Closure
11-11-2011 Glenmark Pharmaceuticals Limited - Outcome of meeting
13-07-2011 Glenmark Pharmaceuticals Limited - Press Release
31-08-2012 Glenmark Pharmaceuticals Limited - Proceedings of Annual General Meeting
23-10-2014 Glenmark Pharmaceuticals Limited - Postal Ballot Updates
25-02-2015 Glenmark Pharmaceuticals Limited - Press Release
25-08-2014 Glenmark Pharmaceuticals Limited - Annual General Meeting Updates
31-10-2014 Glenmark Pharmaceuticals Limited - Outcome of Board Meeting
26-03-2013 Glenmark Pharmaceuticals Limited - Allotment of Securities
31-01-2012 Glenmark Pharmaceuticals Limited - Appointment
12-09-2014 Glenmark Pharmaceuticals Limited - Disclosure under Insider Trading Regulation
09-07-2013 Glenmark Pharmaceuticals Limited - Disclosure under Insider Trading Regulation
18-04-2013 Glenmark Pharmaceuticals Limited - ESOPs/ESOS/ESPS
25-07-2014 Glenmark Pharmaceuticals Limited - Outcome of Board Meeting
08-11-2010 Glenmark Pharmaceuticals Limited - Press Release
02-09-2011 Glenmark Pharmaceuticals Limited - Proceedings of Annual General Meeting
20-07-2015 Glenmark Pharmaceuticals Limited - Trading Window
13-01-2012 Glenmark Pharmaceuticals Limited - Updates
27-01-2016 Glenmark Pharmaceuticals Limited - Regulation 44(3) of SEBI (LODR), Reg., 2015
13-04-2016 Glenmark Pharmaceuticals Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011
31-08-2015 Glenmark Pharmaceuticals Limited - AGM/Book Closure
08-07-2013 Glenmark Pharmaceuticals Limited - AGM/Book Closure
19-11-2010 Glenmark Pharmaceuticals Limited - Allotment of Securities
18-02-2013 Glenmark Pharmaceuticals Limited - GlESOPs/ESOS/ESPS
14-11-2011 Glenmark Pharmaceuticals Limited - Outcome of Board Meeting
09-01-2013 Glenmark Pharmaceuticals Limited - Updates
08-11-2011 Glenmark Pharmaceuticals Limited - Updates
28-05-2014 Glenmark Pharmaceuticals Limited - Disclosure under Insider Trading Regulation
21-11-2014 Glenmark Pharmaceuticals Limited - Disclosure of Voting Pattern - Clause 35A
20-07-2016 Glenmark Pharmaceuticals Limited - Date of payment of dividend
06-02-2017 Glenmark Pharmaceuticals Limited - Reply to Clarification Sought
23-09-2015 Glenmark Pharmaceuticals Limited - Disclosure of Voting Pattern - Clause 35A
26-07-2011 Glenmark Pharmaceuticals Limited - Updates
14-01-2015 Glenmark Pharmaceuticals Limited - Updates
31-12-2014 Glenmark Pharmaceuticals Limited - Disclosure of Voting Pattern - Clause 35A
31-01-2014 Glenmark Pharmaceuticals Limited - Amalgamation/Merger
07-08-2012 Glenmark Pharmaceuticals Limited - Demise
28-07-2014 Glenmark Pharmaceuticals Limited - Disclosure of Voting Pattern - Clause 35A
08-05-2013 Glenmark Pharmaceuticals Limited - Dividend
11-08-2011 Glenmark Pharmaceuticals Limited - Outcome of Annual General Meeting
08-08-2012 Glenmark Pharmaceuticals Limited - Outcome of Annual General Meeting

Gross Deliverables
Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover
24-03-2017 13355 28565 46.75 11850560 25381.70
23-03-2017 12957 37649 34.42 11568658 33635.70
22-03-2017 16328 34184 47.77 14438851 30189.00
21-03-2017 14123 38904 36.30 12568058 34494.20
20-03-2017 11846 35294 33.56 10428627 31039.80


Bulk Deals
Deal Date Client Name Type Qty Price
31-08-2015 DB INTERNATIONAL ASIA LIMITED S 2229553 1154.52
31-08-2015 DB INTERNATIONAL ASIA LIMITED B 139708 1158.66
31-08-2015 ISHARES INDIA INDEX MAURITIUS COMPANY B 1701101 1159.50



Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action




Market on Mobile



Hot Searches  •  reliance communications  •  apar industries  •  service  •  pnc infra  •  punjab chemical
Site Map  •  Companies  •  Learning Centre  •  Insurance  •  About  •  Contact us  •  Disclaimer
© appuonline.com

Content Provided by CMOTS InfoTech